Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

February 29, 2008

Study Completion Date

May 31, 2008

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG

imatinib

DRUG

cyclophosphamide

DRUG

daunorubicin

DRUG

vincristine

DRUG

prednisolone

DRUG

methotrexate

DRUG

cytarabine

DRUG

dexamethasone

Trial Locations (1)

Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya

All Listed Sponsors

lead

Japan Adult Leukemia Study Group

OTHER

NCT00130195 - Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) | Biotech Hunter | Biotech Hunter